Report overview
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide.
This report aims to provide a comprehensive presentation of the global market for ?-Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ?-Nicotinamide Mononucleotide. This report contains market size and forecasts of ?-Nicotinamide Mononucleotide in global, including the following market information:
Global ?-Nicotinamide Mononucleotide Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global ?-Nicotinamide Mononucleotide Market Sales, 2018-2023, 2024-2032, (Tons)
Global top five ?-Nicotinamide Mononucleotide companies in 2022 (%)
The global ?-Nicotinamide Mononucleotide market was valued at US$ 262.7 million in 2022 and is projected to reach US$ 451.3 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core ?-nicotinamide mononucleotide (NMN) manufacturers include GeneHarbor, Herbalmax and Genex Formulas etc. The top 3 companies hold a share about 74%.Asia-Pacific is the largest market, with a share about 70%, followed by Americas with the share about 25%.
We has surveyed the ?-Nicotinamide Mononucleotide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ?-Nicotinamide Mononucleotide Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (Tons)
Global ?-Nicotinamide Mononucleotide Market Segment Percentages, by Type, 2022 (%)
Above 98%
?98%
Global ?-Nicotinamide Mononucleotide Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (Tons)
Global ?-Nicotinamide Mononucleotide Market Segment Percentages, by Application, 2022 (%)
Drug
Health Products
Cosmetic
Others
Global ?-Nicotinamide Mononucleotide Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (Tons)
Global ?-Nicotinamide Mononucleotide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ?-Nicotinamide Mononucleotide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies ?-Nicotinamide Mononucleotide revenues share in global market, 2022 (%)
Key companies ?-Nicotinamide Mononucleotide sales in global market, 2018-2023 (Estimated), (Tons)
Key companies ?-Nicotinamide Mononucleotide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GeneHarbor
Quicksilver Scientific
Age Science
Herbalmax
Genex Formulas
Nutravita
Shinkowa Pharmaceutical
Oriental Yeast
Maac10 Formulas
EffePharm
Nutriop
Bontac
CELFULL
ChromaDex
Kingdomway
Outline of Major Chapters:
Chapter 1: Introduces the definition of ?-Nicotinamide Mononucleotide, market overview.
Chapter 2: Global ?-Nicotinamide Mononucleotide market size in revenue and volume.
Chapter 3: Detailed analysis of ?-Nicotinamide Mononucleotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of ?-Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global ?-Nicotinamide Mononucleotide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
